Clinical Trial Update: Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining the combination of phenylbutyrate and azacitidine in patients with acute myeloid leukemia, myelodysplastic syndromes, no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Multiple Myeloma
• Myelodysplastic Syndromes
• Non-hodgkin Lymphoma
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Leukemia, Lung Cancer | Phase 2 | Status: COMPLETED